Source: Artherosclerosis. Unidade: FM
Subjects: INFARTO DO MIOCÁRDIO, ALGORITMOS, CALCIFICAÇÃO FISIOLÓGICA, CORONARIOPATIA, PROTEÍNAS, ARTERIOSCLEROSE (FISIOPATOLOGIA)
ABNT
SPOSITO, Andrei C et al. Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein. Artherosclerosis, v. 214, n. 1, p. 148-150, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2010.10.034. Acesso em: 12 jun. 2024.APA
Sposito, A. C., Alvarenga, B. F., Alexandre, A. S., Araújo, A. L. R., Santos, S. N., Andrade, J. M., et al. (2011). Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein. Artherosclerosis, 214( 1), 148-150. doi:10.1016/j.atherosclerosis.2010.10.034NLM
Sposito AC, Alvarenga BF, Alexandre AS, Araújo ALR, Santos SN, Andrade JM, Ramires JAF, Silva JCQ e, Coelho OR. Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein [Internet]. Artherosclerosis. 2011 ; 214( 1): 148-150.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.10.034Vancouver
Sposito AC, Alvarenga BF, Alexandre AS, Araújo ALR, Santos SN, Andrade JM, Ramires JAF, Silva JCQ e, Coelho OR. Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein [Internet]. Artherosclerosis. 2011 ; 214( 1): 148-150.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.10.034